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ABSTRACT
Objective: To compare cancer screening and ﬂu
vaccination among persons with and without
unhealthy substance use.
Design: The authors analysed data from 4804
women eligible for mammograms, 4414 eligible for
Papanicolou (Pap) smears, 7008 persons eligible
for colorectal cancer (CRC) screening and 7017
persons eligible for ﬂu vaccination. All patients were
screened for unhealthy substance use. The main
outcome was completion of cancer screening and
ﬂu vaccination.
Results: Among the 9995 patients eligible for one or
more of the preventive services of interest, 10%
screened positive for unhealthy substance use.
Compared with women without unhealthy substance
use, women with unhealthy substance use received
mammograms less frequently (75.4% vs 83.8%;
p<0.0001), but Pap smears no less frequently (77.9%
vs 78.1%). Persons with unhealthy substance use
received CRC screening no less frequently (61.7% vs
63.4%), yet received ﬂu vaccination less frequently
(44.7% vs 50.4%; p¼0.01). In multivariable analyses,
women with unhealthy substance use were less likely
to receive mammograms (adjusted odds ratio 0.68;
95% CI 0.52 to 0.89), and persons with unhealthy
substance use were less likely to receive ﬂu
vaccination (adjusted odds ratio 0.81; 95% CI 0.67 to
0.97).
Conclusions: Unhealthy substance use is a risk factor
for not receiving all appropriate preventive health
services.
INTRODUCTION
Cancer and ﬂu are among the leading causes
of mortality in the USA.
1 2 Flu is preventable,
in part, through vaccination, and mortality
from cervical, breast and colorectal cancer
(CRC) can be reduced through routine
screening.
3e5 Nevertheless, many eligible US
adults do not receive these recommended
preventive services,
6 in particular, low-income
persons,
7 racial and ethnic minorities,
8e11 the
uninsured
12 and the foreign-born.
13 Despite
this knowledge, and the implementation of
interventions targeting these groups, preven-
tive services are still underused, which has led
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ARTICLE SUMMARY
Article focus
- Do persons with unhealthy substance use receive
breast, cervical and colorectal cancer screening
less frequently than persons without unhealthy
substance use?
- Do persons with unhealthy substance use receive
ﬂu vaccination less frequently than persons
without unhealthy substance use?
Key messages
- Women with unhealthy substance use are less
likely to receive mammograms than women
without unhealthy substance use.
- Persons with unhealthy substance use are less
likely to receive ﬂu vaccination than persons
without unhealthy substance use.
- Unhealthy substance use is not a risk factor for
not receiving cervical or colorectal cancer
screening.
Strengths and limitations of this study
- Strengths: the study used validated measures of
unhealthy substance use and encompassed
a wide range of substance-use severity.
- Limitations: the ﬁndings from our sample of an
inner-city patient population with health insur-
ance and access to care who receive primary
care at an urban safety-net hospital may not be
generalisable to other patient populations. The
study cannot determine whether unhealthy
substance use causes patients not to receive
certain services, or whether screening, brief
intervention and substance-use treatment led
some patients to complete screenings or vacci-
nation. The study did not obtain records of
services performed outside Boston Medical
Center, and relied on patient self-report of
substance use.
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Open Access Researchsome to believe that high-risk ‘pockets’ of the population
may account for gaps in service receipt. Persons with
unhealthy substance use (for alcohol, the spectrum that
ranges from risky use to dependence; for drugs, the
spectrum from any illicit drug use (including prescrip-
tion drugs) to dependence) may represent one such
‘pocket.’ Disorganisation, intoxication, comorbid mental
illness and low utilisation of primary care among persons
with unhealthy substance use
14 might lead to lower use of
preventive services.
Prior studies of cancer screening
15e19 and ﬂu vacci-
nation
18 20 suggest that receipt of these services may be
low among persons with substance-use disorders (with
levels of use that are severe enough to warrant a diag-
nosis of abuse or dependence). These studies have been
limited by their reliance on ICD-9 codes to deﬁne
substance-use disorders, their exclusion of persons
whose substance use is undiagnosed or does not meet
criteria for abuse or dependence, and the fact that they
have largely been conducted in Veterans Administration
(VA) settings, where patients may not be representative
of the general population.
We analysed data on unhealthy substance use collected
prospectively and systematically by staff whose sole
responsibility across a variety of healthcare settings was
screening with brief intervention for substance use, and
referral to treatment for substance-use disorders. We
linked these data to electronic medical record data at
eight urban safety-net hospital-based primary care prac-
tices to examine preventive service receipt among
persons with and without unhealthy substance use. We
hypothesised that persons with unhealthy substance use
would receive preventive services less frequently than
persons without unhealthy substance use.
METHODS
Study setting and sample
Boston Medical Center is an urban safety-net hospital
with eight academic primary care practices staffed by 105
primary care practitioners, including both general
internists and family practitioners, and staff and resident
physicians. The primary care practices predominantly
serve a minority and multicultural low-income popula-
tion. We identiﬁed women eligible for breast cancer
screening, women eligible for cervical cancer screening,
and men and women eligible for CRC screening. Among
these groups examined for cancer screening, we also
identiﬁed individuals eligible for ﬂu vaccination. We
linked these four cohorts of patients to unhealthy
substance-use screening data that were obtained over
a similar time period in the outpatient, inpatient, and
emergency department settings.
From 2007 to the present, Boston Medical Center
participated in a universal substance-use screening
programme supported by the federal government
known as the Massachusetts Screening, Brief Interven-
tion, Referral and Treatment (MASBIRT) programme.
As part of the programme, trained lay-persons ask the
following three questions of all patients in multiple
settings to identify unhealthy substance use:
1. In the past 3 months, how often have you had more
than four drinks (with alcohol) in a day (for men;
women and men 65 years and over were asked about
more than three drinks in a day)?
2. In the past 3 months, how often have you used
narcotic pain medicines, sedatives (benzodiazepines),
or Ritalin/amphetamine without a doctor’s prescrip-
tion or in greater amounts than prescribed?
3. In the past 3 months, how often have you used
marijuana, cocaine, heroin or other drugs?
Unhealthy substance use was deﬁned as any response
other than ‘never’ to any of the above questions. In its
clinician’s guide, the National Institute on Alcohol
Abuse and Alcoholism recommends the single-question
screen for unhealthy alcohol use (similar to question 1
above).
21 Smith et al validated the single-question screen
at Boston Medical Center, ﬁnding that it is both sensitive
and speciﬁc for the detection of unhealthy alcohol use.
22
Since brief validated screening questions for illicit drug
use or prescription drug misuse in the primary care
setting have only recently been published,
23 the
MASBIRT programme used screening questions (ques-
tions 2 and 3 above) that were derived from the more
extensive Alcohol, Smoking and Substance Involvement
Screening Test (ASSIST) questionnaire
24 (validated in
primary care settings) and the National Household
Survey on Drug Use and Health.
25 The MASBIRT
programme speciﬁcally asked about marijuana, cocaine
and heroin, as these are the three most common illicit
drugs used in Massachusetts.
26 Instead of past-year use,
all screening questions asked about use in the past
3 months to increase the likelihood that a positive test
would make logical sense for a clinician to address
(current use) and to match the time frame in the ASSIST
questionnaire. The ASSIST questionnaire was adminis-
tered to all patients who reported drug use or risky
alcohol use(anafﬁrmativeresponsetoquestion 1above),
providing a measure of current (or risk of developing)
substance-related problems. We deﬁned high-risk drug
use according to a WHO ASSIST Speciﬁc Substance
Involvement Score of $27, moderate-risk drug use as
a score of 4e26 and low-risk drug use as a score of 0e3.
27
Similarly, we deﬁned high-risk alcohol use as a score of
$27, moderate-risk alcohol use as a score of 11e26 and
low-risk alcohol use as a score of 0e10. Patients who
screened positive for unhealthy substance use received
a single brief counselling intervention and, if indicated,
referral for addiction treatment.
We linked clinical information to data on unhealthy
substance use among individuals who were screened for
unhealthy substance use from 2007 to 2009. We based
our eligibility criteria for the cancer-screening measures
on modiﬁed versions of the corresponding 2007 Health-
care Effectiveness Data and Information Set (HEDIS)
measures and recommendations of the US Preventive
Services Task Force,
3 28e30 and eligibility criteria for ﬂu
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31 The Boston Medical
Center institutional review board approved the study
protocol.
Preventive service measures
Using a clinical data warehouse that makes electronic
medical records available for research, we identiﬁed
three groups of patients: (1) female patients aged
21e64 years; (2) female patients aged 42e69 years; and
(3) male and female patients age 51e75 years. We chose
these age ranges because we sought consistency with the
HEDIS measures on cervical- and breast-cancer
screening (groups 1 and 2, respectively), and with the
United States Preventive Services Task Force recom-
mendations on CRC screening (group 3).
29 Given the
questionable value of CRC screening in persons with
limited life expectancy,
32 we chose to follow the United
States Preventive Services Task Force colorectal cancer
recommendations, with age 75 as an upper age limit of
screening, rather than age 80, as speciﬁed by HEDIS.
We modiﬁed the denominator of the cervical cancer
screening measure to include any female patient aged
21e64 who had at least one visit to a primary care site at
Boston Medical Center in each of the three previous
years. We required a minimum of one visit per year to
approximate the HEDIS requirement that patients be
‘continuously enrolled’ in a health plan. The numerator
included any patient who received a Papanicolou (Pap)
smear in the past 3 years. We excluded women who had
undergone a hysterectomy (based on current procedural
terminology (CPT) and International Classiﬁcation of
Diseases, version 9 (ICD-9) codes) from both the
numerator and the denominator, as Pap smears are
rarely indicated in this group.
30
For the breast-cancer screening measure, we required
that female patients aged 42e69 have one visit to
a hospital primary care site in each of the two previous
years. The numerator included any patient who received
a mammogram in the past 2 years. We excluded women
who had undergone a bilateral mastectomy or unilateral
mastectomyontwoseparatedates(basedonCPTandICD-
9 codes) from both the numerator and the denominator.
For the CRC screening measure, we required that
patients aged 51e75 have one visit to a Boston Medical
Center primary care site in each of the two previous
years. The numerator included any patient who
completed home faecal occult blood cards (based on
results in the electronic medical record) in the past year,
ﬂexible sigmoidoscopy or barium enema in the past
5 years, or colonoscopy in the past 10 years.
We also examined whether patients eligible for
cervical, breast and CRC screening who were eligible for
ﬂu vaccination were vaccinated. Patients were eligible
for ﬂu vaccination as per CDC recommendations during
this period if they were aged 65 or older or had one of
the following chronic conditions: asthma, chronic
obstructive pulmonary disease, congestive heart failure,
moderate or severe liver disease, HIV infection, diabetes
mellitus or renal insufﬁciency.
Covariate measures
Guided by Gelberg’s adaptation of Andersen’s model of
health services use,
33 we examined covariates known to
affect healthcare utilisation such as gender, race, age,
insurance status and language. We deﬁned the burden
of medical comorbidity by using the Deyo adaptation of
the Charlson Comorbidity Index.
34 Patients were cate-
gorised as having signiﬁcant comorbidity if they had
a CharlsoneDeyo Score of one or greater. We obtained
psychiatric diagnoses from the electronic medical record
problem list. In most cases, these diagnoses were made
by the patient’s primary care provider or by a mental-
health specialist. We also examined primary-care utilisa-
tion, analysing the number of primary-care visits over the
study period.
Statistical methods
Using the SAS computer statistical package, Version 9.1,
we performed c
2 tests to compare differences in preven-
tive-services receipt between persons with and without
unhealthy substance use. In exploratory subgroup anal-
yses, we also compared differences in preventive-services
receipt between persons with and without unhealthy
alcohol use, and with and without any drug use. We used
multiple logistic regression to analyse unhealthy
substance use as a predictor of receiving each preventive
service. Data were missing at random among <5% of all
observations.Weincludedallvariablesinthemodelbased
on their a priori clinical signiﬁcance, and computed
adjusted ORs and 95% CIs based on the multiple logistic
model. To minimise the potential for collinearity, we
examined the variance inﬂation factor for each covariate.
Analyses were conducted using two-sided tests and
a signiﬁcance level of 0.05. We used general estimating
equations to account for clustering of patients within
clinicians, and clinicians within practices. To detect
differences between men and women with unhealthy
substance use, we included interaction terms between
unhealthy substance use and sex in the multivariable
models of CRC screening and ﬂu vaccination.
RESULTS
There were 9995 primary care patients who were eligible
for one ofthepreventiveservices ofinterestandhad been
screened for unhealthy substance use from 2007 to 2009.
Table 1 shows the demographic and clinical characteris-
tics of the sample. Patients with unhealthy substance use
were slightly younger, and were more likely to be male,
English-speaking and of white or black race (vs Hispanic
or other race) than were patients without unhealthy
substanceuse.Patientswithunhealthysubstanceusewere
alsolesslikely tohaveprivateinsuranceand morelikely to
have Medicaid or Commonwealth Care (a Massachusetts
insurance programme for poor and near-poor uninsured
adults). Approximately 10% of the sample screened
positive for unhealthy substance use. Among these
patients, most had unhealthy alcohol use (72.3%), 41.7%
had any illicit drug use, and 30.0% had any marijuana
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use (4.1% and 2.5%, respectively). A higher proportion
of patients with unhealthy substance use had a mental
disorder (p<0.0001) or signiﬁcant medical comorbidity
(p¼0.04) relative topatients without unhealthysubstance
use.Primarycareutilisation didnot differamongpatients
with and without unhealthy substance use.
In bivariable analyses, patients with unhealthy
substance use were signiﬁcantly less likely to receive
mammograms or ﬂu vaccination than were patients
Table 1 Demographic and clinical characteristics of patients engaged in primary care and screened for unhealthy substance
use (SU) in Boston, Massachusetts between 2007 and 2009*
Variable
Unhealthy SU
n[975 (%)
No unhealthy SU
n[9020 (%) p Value
Mean (SD) age 52.1 (12.3) 54.7 (12.5) <0.001
Gender, female 52.0 72.6 <0.0001
Language
English 93.5 73.2 <0.0001
Spanish 4.4 7.6
Haitian Creole 0.7 9.5
Other 1.3 9.7
Racey
White 21.6 15.9 <0.0001
Black/AfricaneAmerican 63.3 55.3
Hispanic/Latino 10.8 31.1
Other 4.3 15.8
Insurance
Medicare 29.3 29.8 <0.0001
Health maintenance organization 20.1 26.3
Medicaid 22.8 17.4
Free care 5.5 7.7
Commonwealth carez 20.0 16.1
Other 2.3 2.6
Six or more primary care visits over study period 51.9 53.8 0.25
Signiﬁcant medical comorbidityx 58.0 54.5 0.04
SU severity
Unhealthy alcohol use{ 72.3
Any drug use, past 3 months 41.7
Marijuana 30.0
Cocaine 9.0
Any opioids 7.0
Drug Involvement Score**
Low risk 70.4
Moderate risk 27.2
High risk 2.5
Alcohol Involvement Scoreyy
Low risk 77.4
Moderate risk 18.5
High risk 4.1
Any mental disorder 44.6 35.8 <0.0001
Anxiety 15.4 12.4 0.008
Bipolar disorder 3.9 1.6 <0.0001
Depression 37.4 28.6 <0.0001
Post-traumatic stress disorder 5.9 3.7 0.0006
Panic disorder 1.7 1.5 0.61
Schizophrenia 0.82 1.2 0.28
*Data presented are for unique patients from all four cohorts of patients: (1) women eligible for mammograms (n¼4804), (2) women eligible for
Papanicolaou tests (n¼4414), (3) men and women eligible for colorectal cancer screening (n¼7008) and (4) men and women from cohorts 1, 2
and 3 who were eligible for ﬂu vaccination (n¼7017).
yPatient race and ethnicity were determined by clinical registration staff.
zCommonwealth Care, a Massachusetts insurance programme for poor and near-poor uninsured adults.
xCharlsoneDeyo Score of $1.
{Deﬁned as more than four drinks with alcohol in 1 day within the past 3 months (for men; more than three drinks with alcohol for women and
men over 65 years).
**Risk level based on WHO Alcohol Smoking and Substance Involvement Screening Test Speciﬁc Substance Involvement Score. A score of
0e3 is deﬁned as low risk, 4e26 as moderate risk and $27 as high risk.
yyRisk level based on WHO Alcohol Smoking and Substance Involvement Screening Test Speciﬁc Substance Involvement Score. A score of
0e10 is deﬁned as low risk, 11e26 as moderate risk and $27 as high risk.
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with unhealthy alcohol use were less likely to receive
mammograms, while patients with any drug use were less
likely to receive ﬂu vaccination or mammograms (p<0.05
for all comparisons). Patients with and without unhealthy
substance use did not differ in their receipt of colorectal
or cervical cancer screening. Among women who were
eligible for both a mammogram and a Pap smear, fewer
women with unhealthy substance use (56.5%) completed
bothtestswhencomparedwithwomenwithoutunhealthy
substance use (64.5%, p¼0.02).
In the multivariable model predicting receipt of
mammograms, unhealthy substance use was signiﬁcantly
associated with a lower odds of mammogram receipt
(OR 0.69, CI 0.59 to 0.80). Unhealthy substance use was
also signiﬁcantly associated with a lower odds of ﬂu
vaccination receipt (OR 0.80, CI 0.66 to 0.97). There
were no signiﬁcant interactions between gender and
unhealthy substance use for either CRC screening or ﬂu
vaccination. Unhealthy substance use was not an inde-
pendent predictor of receiving the other preventive
services assessed (table 3).
DISCUSSION
Among this sample of patients engaged in primary care,
women who screened positive for unhealthy substance
use received mammography screening less frequently
than women who screened negative. Similarly, men and
women who screened positive for unhealthy substance
use were less likely to receive ﬂu vaccination than other
patients. Not withstanding this identiﬁed disparity in the
provision of preventive services, delivery of appropriate
preventive clinical care in this primary care patient
sample was remarkably high, when compared with
national estimates.
35 We speculate that persons with
unhealthy substance use who are not engaged in primary
care at the high thresholds used in these analyses may
have substantially lower receipt of preventive services.
Notably, patients with any drug use (which in this study
was predominantly marijuana) were also less likely to
receive mammography screening and ﬂu vaccination.
Because marijuana users are more likely to use
tobacco,
36 lower receipt of ﬂu vaccination may have
particular clinical signiﬁcance. Despite large numbers of
patients with marijuana use, there are very few studies of
Table 2 Use of cancer-screening services and ﬂu vaccination according to substance-use characteristics between 2007 and
2009 in Boston, Massachusetts
Flu vaccination
(n[7017), %
Pap smear
(n[4414), %
Mammogram
(n[4804), %
Colorectal cancer
screening (n[7008), %
Substance use
None 50.4 78.1 83.8 63.4
Unhealthy substance use* 44.7y 77.9 75.4z 61.7
Unhealthy alcohol use 45.7 79.1 78.2x 61.1
Any drug use 41.7y 75.5 70.0z 60.8
*Unhealthy alcohol or any drug use.
ySigniﬁcantly different from persons without unhealthy substance use, c
2 p#0.01.
zSigniﬁcantly different from persons without unhealthy substance use, c
2 p<0.0001.
xSigniﬁcantly different from persons without unhealthy substance use, c
2 p<0.05.
Table 3 Multivariable analyses of the association between unhealthy substance use and receipt of preventive services by
primary care patients* between 2007 and 2009 in Boston, Massachusetts
Flu vaccination
OR (95% CI)
Pap smear
OR (95% CI)
Mammogram
OR (95% CI)
Colorectal cancer
screening OR (95% CI)
Unhealthy substance use 0.80 (0.66 to 0.97) 0.95 (0.70 to 1.29) 0.69 (0.59 to 0.80) 0.93 (0.74 to 1.17)
Older agey 1.49 (1.31 to 1.70) 0.30 (0.26 to 0.35) 1.55 (1.26 to 1.90) 0.98 (0.85 to 1.14)
Female 0.74 (0.68 to 0.82) NA NA 0.91 (0.80 to 1.04)
Public insurancez 1.10 (0.98 to 1.24) 0.92 (0.81 to 1.06) 0.86 (0.74 to 0.99) 0.78 (0.66 to 0.93)
Black race 0.79 (0.69 to 0.90) 1.11 (0.98 to 1.26) 1.05 (0.93 to 1.19) 0.94 (0.85 to 1.04)
English-speaking 0.94 (0.77 to 1.14) 0.84 (0.65 to 1.08) 0.75 (0.66 to 0.86) 1.01 (0.84 to 1.22)
Medical comorbidityx 1.54 (1.17 to 2.02) 0.73 (0.57 to 0.93) 0.88 (0.74 to 1.05) 0.98 (0.92 to 1.05)
Psychiatric comorbidity{ 1.20 (1.13 to 1.29) 0.93 (0.74 to 1.18) 0.73 (0.64 to 0.83) 1.04 (0.93 to 1.15)
High primary-care-practice
utilisation**
1.89 (1.70 to 2.11) 1.02 (0.78 to 1.33) 1.60 (1.14 to 2.26) 1.59 (1.40 to 1.81)
*The variable unhealthy substance use was included in all models as it is the primary predictor of interest.
yAnalyses of ﬂu vaccination receipt compared patients aged 65e75 with those aged 21e64; analyses of Papanicolou (Pap) smear receipt
compared patients aged 50e64 with those aged 21e49; analyses of mammogram receipt compared patients aged 50e69 with those aged
40e49; analyses of receipt of colorectal cancer screening compared patients aged 65e75 with those aged 50e64.
zDeﬁned as Free Care, Medicaid or Commonwealth Care (the new subsidised Massachusetts insurance programme).
xDeﬁned as CharlsoneDeyo Score of 1 or greater.
{Deﬁned as diagnosis of anxiety, bipolar, depression, post-traumatic stress disorder, panic or schizophrenia on medical problem list.
**Deﬁned as at least six primary care visits in the past 2 years for patients eligible for mammograms and ﬂu vaccination, and at least six primary
care visits in the past 3 years for patients eligible for Pap smears and colorectal cancer screening.
Lasser KE, Kim TW, Alford DP, et al. BMJ Open 2011;1:e000046. doi:10.1136/bmjopen-2010-000046 5
Unhealthy substance use and preventive caremarijuana and health-services use.
37 Unexpectedly, the
proportions of patients with cervical and CRC screening
were not lower among persons with unhealthy substance
use. It is possible that substance-using women are more
likely to have unprotected sex, contract sexually trans-
mitted diseases and then visit a women’s health provider
who may offer cervical-cancer screening.
38 39 Further, in
the medical care system in which this study was
performed, a Pap smear can be carried out at the time it
is recommended, whereas a mammogram must be
scheduled on a different day. This additional require-
ment to schedule a new appointment on a different day
and arrange transportation, and possibly childcare, may
explain why women with substance-use disorders had
lower odds of receiving mammograms but were no less
likely to receive Pap tests. CRC screening is the most
complex of the screening services that we examined,
potentially requiring advanced scheduling, administra-
tion of the preparation and having someone accompany
the patient home after the procedure. Thus, there may
be other factors more important than substance use
affecting its completion. Furthermore, before stating
that unhealthy substance use does not appear to be
a barrier to completion of this most involved screening
test, alternative possibilities merit examination such as
disproportionately high numbers with evaluation of
gastrointestinal bleeds in this population compensating
for fewer with standard screening evaluations.
Prior studies found lower rates of CRC screening
among veterans with substance-use disorders.
17 18 The
lack of a difference in completion of CRC screening in
our study between those with and without unhealthy
substance use may be explained by inclusion of the
spectrum from mild to severe in that deﬁnition, as
opposed to limiting substance use to the most severe,
those with substance-use disorders. Our ﬁnding of
a lower frequency of mammogram and ﬂu vaccination
receipt and a similar frequency of Pap smear receipt
among women with unhealthy substance use is consis-
tent with prior studies.
15 18e20 Our study also showed
a lower odds of mammogram receipt among English
speakers. It is possible that unmeasured confounders
such as low socio-economic status, low health literacy
and lower levels of education may account for this
ﬁnding. Our observation of a lower odds of mammo-
gram receipt among individuals with psychiatric comor-
bidity is consistent with prior studies,
15 yet contradicts
our prior work.
19 In the latter study, primary care and
mental-health services were well integrated, which may
have accounted for improved preventive screenings
among persons with mental illness. It is also possible that
individuals with psychiatric comorbidity are more likely
to receive preventive services because of their more
frequent contact with the health system. Yet, the pres-
ence of psychiatric comorbidity can also decrease the
likelihood of receiving services if the service requires
patient organisation to attend an appointment or to take
a preparation. Our ﬁnding of a lower odds of Pap tests
among women with medical comorbidity is consistent
with prior studies.
40
This study has several limitations. The ﬁndings from
our sample of an inner-city patient population with health
insurance and access to care who receive primary care at
an urban safety-net hospital may not be generalisable to
other patient populations. Yet, the fact that patients were
insured and engaged in primary care helps to isolate the
effect of substance use on service receipt. We also cannot
determine whether unhealthy substance use causes
patients not to receive certain services, or whether
screening, brief intervention and substance-use treatment
led some patients to complete screenings or vaccination.
Further, the periods during which patients were screened
for unhealthy substance use and were eligible to receive
preventive services overlapped, but some patients may
have been screened for unhealthy substance use before or
after primary care visits in which prevention was
addressed. For example, a patient may have been
screened by colonoscopy several years ago, yet was found
to have unhealthy substance use more recently. In such
cases, it may be difﬁcult to draw conclusions about the
association between obtaining a colonoscopy and having
substance use. However, the chronic, relapsing and
remitting nature of substance use suggests that such use
may inﬂuence preventive-healthcare utilisation over time.
We did not obtain any records of services performed
outside Boston Medical Center. We believe that it is
unlikely that patients receiving primary care at Boston
Medical Center would have sought and received primary
preventive care elsewhere, with the possible exception of
the ﬂu vaccine, which is widely available in the commu-
nity. But even if patients had received services elsewhere,
such use would have been associated with non-differen-
tial misclassiﬁcation bias, as we suspect patients with
unhealthy substance use are no more likely than other
patients to obtain care in other health systems. In
multivariable analyses, we observed higher rates of ﬂu
vaccination among those with psychiatric comorbidity. It
is possible that such patients are less likely than others to
seek preventive care outside Boston Medical Center. We
relied on patient self-report of substance use. Others
have found that self-report of substance use is valid when
there are assurances of conﬁdentiality and when vali-
dated tools are used.
23 While we used a validated tool, it
is possible that some patients under-reported their
substance use in the clinical setting. Such under-
reporting would have biased our ﬁndings to the null.
CONCLUSION
In conclusion, our ﬁndings suggest that unhealthy
substanceuseisabarriertocompletionofmammography
screening and ﬂu vaccination. Future interventions to
promote mammography screening might target women
with unhealthy substance use, and those to promote ﬂu
vaccination might target both men and women with
unhealthy substance use. Clinical interventions could
embed mammography screening and ﬂu vaccination in
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problems. Training interventions could enhance skills
and systems for healthcare personnel who screen for
substance-usedisorderstoincludereferralsforpreventive
health services.
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